Polyneuron Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Liquidation

Polyneuron Pharmaceuticals General Information

Description

Developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders safely and effectively.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polyneuron Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation Completed Bankruptcy: Liquidation
10. Grant 14-Apr-2021 Completed Generating Revenue
9. Later Stage VC (Series A) 28-Aug-2020 Completed Pre-Clinical Trials
8. Seed Round 14-May-2018 Completed Pre-Clinical Trials
7. Accelerator/Incubator 18-Sep-2017 Completed Pre-Clinical Trials
6. Grant 31-Aug-2017 Completed Pre-Clinical Trials
5. Seed Round 12-May-2016 Completed Pre-Clinical Trials
4. Grant 05-May-2016 Completed Pre-Clinical Trials
3. Accelerator/Incubator 15-Jul-2015 $3.35K $3.35K Completed Startup
2. Grant 01-Oct-2014 $32K Completed Pre-Clinical Trials
To view Polyneuron Pharmaceuticals’s complete valuation and funding history, request access »

Polyneuron Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Seed
To view Polyneuron Pharmaceuticals’s complete cap table history, request access »

Polyneuron Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The compa
Drug Discovery
Basel, Switzerland
9 As of 2022

Hannover, Germany
 

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Polyneuron Pharmaceuticals Competitors (35)

One of Polyneuron Pharmaceuticals’s 35 competitors is Cardior, a Formerly VC-backed company based in Hannover, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardior Formerly VC-backed Hannover, Germany
AnTolRx Formerly VC-backed Cambridge, MA
ImmunOs Therapeutics Venture Capital-Backed Schlieren, Switzerland
Genentech Formerly VC-backed South San Francisco, CA
Voyager Therapeutics Formerly VC-backed Lexington, MA
You’re viewing 5 of 35 competitors. Get the full list »

Polyneuron Pharmaceuticals Patents

Polyneuron Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022224035-A2 Anti-gm1 antibody binding compounds Inactive 20-Apr-2021
WO-2022224035-A3 Anti-gm1 antibody binding compounds Inactive 20-Apr-2021
AU-2018235063-A1 Glycopolymers sequestering carbohydrate-binding proteins Inactive 15-Mar-2017
CA-3056206-A1 Glycopolymers sequestering carbohydrate-binding proteins Inactive 15-Mar-2017
EP-3595730-A1 Glycopolymers sequestering carbohydrate-binding proteins Inactive 15-Mar-2017 C07H15/12
To view Polyneuron Pharmaceuticals’s complete patent history, request access »

Polyneuron Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polyneuron Pharmaceuticals FAQs

  • When was Polyneuron Pharmaceuticals founded?

    Polyneuron Pharmaceuticals was founded in 2014.

  • Where is Polyneuron Pharmaceuticals headquartered?

    Polyneuron Pharmaceuticals is headquartered in Basel, Switzerland.

  • What is the size of Polyneuron Pharmaceuticals?

    Polyneuron Pharmaceuticals has 9 total employees.

  • What industry is Polyneuron Pharmaceuticals in?

    Polyneuron Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Polyneuron Pharmaceuticals a private or public company?

    Polyneuron Pharmaceuticals is a Private company.

  • What is Polyneuron Pharmaceuticals’s current revenue?

    The current revenue for Polyneuron Pharmaceuticals is .

  • How much funding has Polyneuron Pharmaceuticals raised over time?

    Polyneuron Pharmaceuticals has raised $46.3M.

  • Who are Polyneuron Pharmaceuticals’s competitors?

    Cardior, AnTolRx, ImmunOs Therapeutics, Genentech, and Voyager Therapeutics are some of the 35 competitors of Polyneuron Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process